Showing latest transactions and SEC Form 4 filings for HALO.
43 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-11-16 20:33:59 | 2026-11-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | M - OptEx | $17.28 | +120,000 | 10,860,350 | 0% | +$2,073,863 |
| D | 2026-11-16 20:33:59 | 2026-11-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | S - Sale+OE | $100.01 | -60,000 | 10,860,350 | 0% | -$6,000,686 |
| D | 2026-10-08 19:56:19 | 2026-10-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | M - OptEx | $18.41 | +120,000 | 11,648,070 | 0% | +$2,209,200 |
| D | 2026-10-08 19:56:19 | 2026-10-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | S - Sale+OE | $110.18 | -60,000 | 11,648,070 | 0% | -$6,610,501 |
| A | 2026-10-08 19:55:35 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | A | $0.00 | +3,796 | 42,294 | 0% | $0 |
| D | 2026-10-02 16:43:41 | 2026-10-01 | HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Director | A | $0.00 | +2,944 | 1,169 | 0% | $0 |
| M | 2026-10-02 16:38:18 | 2026-10-01 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | S - Sale | $108.54 | -5,230 | 220,236 | -0% | -$567,661 |